Biotest - BT

BT - 061

BT-061 is a humanized, therapeutic monoclonal antibody, which, based on the current state of knowledge, binds to and thus activates special cells of the immune system, the so-called regulatory T cells.

Target indications: (rheumatoid arthritis, psoriasis)
Possible upside indications: systemic lupus erythematosus, inflammatory gastro-intestinal diseases, multiple sclerosis, type 1 diabetes, allergie

Rheumatoid arthritis

Rheumatoid arthritis (RA) is a very painful, chronic inflammatory, disease predominantly afflicting the joints.
more

Psoriasis

Psoriasis is a predominantly chronic skin disease which may also affect the joints. Biotest develops innovative therapeutic strategies with the objective of improving quality of life for psoriasis patients, which is usually severely limited. The focus is on the monoclonal antibody BT-061 with its completely new action mechanism.
more